Project Grant R01AI190087
Award Date 7/1/26
Completion Date 6/30/31
Dollars Obligated $313K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Binghamton, NY 13902, USA
Similar Awards
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Research Foundation for the State University of New York at Binghamton a Project Grant of $380,093 under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 2, 2025, with completion by June 30, 2026. This research project characterizes a two-component regulatory system (SaeRS) in Group B Streptococcus (GBS) that controls bacterial genes essential...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Methodist Hospital Research Institute a Project Grant of $444,125 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 8, 2025, with a completion date of July 31, 2027. This research project will characterize a previously unknown intercellular signaling pathway in Group B Streptococcus (GBS) and determine its contribution to bacterial pathogenesis. Specifically,...
- Federal Grant Award Summary Award: Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) Funding Amount and Timeline: $254,250 obligated for the period July 1, 2026 through June 30, 2028 Products and Services: This two-year research project, conducted by New York University School of Medicine, focuses on investigating the epigenetic mechanisms and evolutionary generality of bacterial...
- Federal Grant Award Summary Seattle Children's Research Institute received a $3.61 million Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on July 14, 2025, with a completion date of June 30, 2029. This research project investigates hyaluronidase (HylB), a virulence factor produced by Group B Streptococci (GBS), to elucidate mechanisms by which the enzyme suppresses immune...
- Federal Grant Award Summary Grant Overview New York University School of Medicine received a $791,797 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 4, 2026, with completion scheduled for January 31, 2031. The award supports biomedical research investigating how the intestinal microbiota programs gut-associated germinal centers (GGCs) and influences B...
- Project Grant Summary: Group B Streptococcus Type VII Secretion Systems and Neonatal Intestinal Disease The National Institute of Allergy and Infectious Diseases awarded $806,000 to the University of Virginia on May 11, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate the mechanisms by which Group B Streptococcus (GBS) causes late-onset systemic disease in neonates. The research will examine how GBS Type VII Secretion System (T7SS) effector proteins...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Research Foundation for the State University of New York (RF SUNY) a Project Grant of $437,895 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 14, 2025, with a completion date of June 30, 2027. The grant supports research to elucidate the mechanistic role of galectin-3-binding protein (LGALS3BP/90K) during severe acute respiratory syndrome coronavirus...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $508,500 to New York University School of Medicine on April 22, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support a postdoctoral research project extending through March 31, 2031. The grant funds investigative research aimed at decoding the molecular mechanisms by which innate immune cells, specifically neutrophils, make functional decisions...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Stony Brook University a $3.13 million Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 23, 2025, with completion targeted for June 30, 2029. The grant funds research to develop new therapeutic strategies targeting STS-1 and STS-2 phosphatases as a means to enhance antimicrobial immune responses. The project deliverables include the identification...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Stony Brook University $466,199 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on June 24, 2026, for a project extending through May 31, 2028. This Project Grant funds basic research to elucidate the mechanistic function of RV1410C, an atypical lipid transporter in Mycobacterium tuberculosis (M. tuberculosis), the human pathogen responsible for approximately 1.3 million...